Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reclast for Bone Loss Prevention in Acute Spinal Cord Injury
NCT02042872Phase 4Completed
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Start
- May 2006
- Primary completion
- Jul 2012
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in disuse osteoporosis, sponsored by James J. Peters Veterans Affairs Medical Center. Started May 2006; status: completed.
02
Drugs
zoledronic acid
03
Conditions
disuse osteoporosis
Beyond the preview
Go deeper on NCT02042872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042872.